Germany – Sickness benefits – Bes. Vers. nach § 140a SGB V zur bildgest. Schmerztherapie im Wirbelsäulenbereich (OH-02/VE/2025)

Health · Germany government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

May 31, 2028
Response Due
Active
Status

Opportunity Overview

Germany – Sickness benefits – Special insurance according to § 140a SGB V for image-guided pain therapy in the spinal region (OH-02/VE/2025)

This is one of 1,699 active Germany Professional Services opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyHealth
CountryGermany
CategoryProfessional Services
PublishedMay 12, 2025
Procurement stageActive solicitation
Response dueMay 31, 2028
StatusOpen — accepting responses
TranslationTranslated from German by GlobalGov’s translation pipeline
Official sourceView original notice
Last verifiedAugust 10, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Related Opportunities in Germany

Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Benralizumab, ATC R03DX10 für die Zeit 01.06.2025 - 31.05.2027
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Brimonidin + Timolol, ATC S01ED69 für die Zeit 01.02.2026 - 31.01.2028 (zzgl. Verlängerungsoption 1x12 Mon.)
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-24 - Vericiguat
Open House Originale Rabattverträge 2025-04 - Emtricitabin/tenofoviralafenamid/rilpivirin (odefsey(r))
Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Vareniclin (ATC: N07BA03)
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Adapalen + Benzoylperoxid, ATC D10AD23 für die Zeit 01.02.2026 - 31.01.2028 (zzgl. V.-Option 1x12 Monate)
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Formoterol und Beclometason dipropionat, ausgenommen Dosieraerosole mit der Wirkstärke 100µg/4,91µg, ATC R03AK08
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Peginterferon beta-1a, ATC L03AB13 für die Zeit 01.05.2025 - 30.04.2027

See every Germany Professional Services opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Professional Services intelligence report in your inbox

A personalized report on Germany Professional Services opportunities, emailed in 5-10 minutes. One per month, no account needed.